Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited Financial Results for the Quarter and half year ended on 30th September, 2026.

CITURGIA BIOCHEMICALS LIMITED Regd. Office: Office No. 427, A-Wing, 4th Floor Floor, Mainframe Premises C.S.L Royal Palms, Aareymilk Colony, Goregaon East, Mumbai-400065 Maharashtra, CIN: L24100MH1974PLC017773 Website: www.citurgiabiochemicals.com; E-mail id: citurgia_bio@yahoo.com To, Date: 05-11-2026 Listing Department, BSE Limited PJ, Towers, Dalal Street, Mumbai-400001 Scrip Code: 506373 Scrip ID: CITURGIA Sub: Intimation of the Board Meeting pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 to consider and approve unaudited Financial Results for the Quarter and half year ended on 30th September, 2026. Dear Sir/ Madam This is to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 14th November, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 to consider and approve the unaudited Financial Results for the Quarter and half year ended on 30th September, 2026. As informed earlier, Trading Window for trading in the Company’s equity shares was closed for the Company’s Directors, Officers, designated employees and other connected persons of the Company from Wednesday, 01st July, 2026 and shall open 48 hours after the aforesaid financial results are declared to Stock Exchanges. Please take the above intimation on your records. Thanking You